Cite
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas.
MLA
Ninatti, Gaia, et al. “Preoperative [11C]Methionine PET to Personalize Treatment Decisions in Patients with Lower-Grade Gliomas.” Neuro-Oncology, vol. 24, no. 9, Sept. 2022, pp. 1546–56. EBSCOhost, https://doi.org/10.1093/neuonc/noac040.
APA
Ninatti, G., Sollini, M., Bono, B., Gozzi, N., Fedorov, D., Antunovic, L., Gelardi, F., Navarria, P., Politi, L. S., Pessina, F., & Chiti, A. (2022). Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas. Neuro-Oncology, 24(9), 1546–1556. https://doi.org/10.1093/neuonc/noac040
Chicago
Ninatti, Gaia, Martina Sollini, Beatrice Bono, Noemi Gozzi, Daniil Fedorov, Lidija Antunovic, Fabrizia Gelardi, et al. 2022. “Preoperative [11C]Methionine PET to Personalize Treatment Decisions in Patients with Lower-Grade Gliomas.” Neuro-Oncology 24 (9): 1546–56. doi:10.1093/neuonc/noac040.